within Pharmacolibrary.Drugs.ATC.P;

model P01CB02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00095,
    adminDuration  = 600,
    adminMass      = 1400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00011,
    k12             = 6,
    k21             = 6
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P01CB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Sodium stibogluconate is a pentavalent antimonial agent used in the treatment of leishmaniasis, particularly visceral and cutaneous leishmaniasis. It is not commonly approved for new use today in developed countries due to emerging resistance and toxicity but is still listed by WHO for neglected tropical diseases.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult male patients with visceral leishmaniasis treated with 20 mg/kg intravenous sodium stibogluconate.</p><h4>References</h4><ol><li><p>Nieto, J, et al., &amp; González, F (2003). Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals. <i>Antimicrobial agents and chemotherapy</i> 47(9) 2781–2787. DOI:<a href=&quot;https://doi.org/10.1128/AAC.47.9.2781-2787.2003&quot;>10.1128/AAC.47.9.2781-2787.2003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12936974/&quot;>https://pubmed.ncbi.nlm.nih.gov/12936974</a></p></li><li><p>Collins, M, et al., &amp; O&#x27;Grady, J (1993). The distribution of free and non-ionic vesicular sodium stibogluconate in the dog. <i>Journal of drug targeting</i> 1(2) 133–142. DOI:<a href=&quot;https://doi.org/10.3109/10611869308996069&quot;>10.3109/10611869308996069</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8069551/&quot;>https://pubmed.ncbi.nlm.nih.gov/8069551</a></p></li><li><p>Baillie, AJ, et al., &amp; Stjärnkvist, P (1987). Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate. <i>The Journal of pharmacy and pharmacology</i> 39(10) 832–835. DOI:<a href=&quot;https://doi.org/10.1111/j.2042-7158.1987.tb05126.x&quot;>10.1111/j.2042-7158.1987.tb05126.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2891821/&quot;>https://pubmed.ncbi.nlm.nih.gov/2891821</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P01CB02;
